CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Investigation of smell and taste disordersWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D013651 Taste Disorders NIH 0.71

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Smell and Taste Disorders in COVID-19 Patients: Prospective Observational Study

This is a prospective monocentric observational study with the aim of investigating the demographic and clinical factors related to the smell and taste disorders in patients with Severe Acute Respiratory Syndrome - Coronavirus - 2 (Sars-Cov-2) infection.

NCT04427332 covid19 Other: Investigation of smell and taste disorders
MeSH:Taste Disorders

Primary Outcomes

Description: Identify the demographic and clinical factors related to the sense of smell and taste in patients with Sars-CoV-2 infection included in the study.

Measure: Identification of demographic and clinical factors in covid19 patients.

Time: Until patient discharge from the hospital (approximately four months)

Secondary Outcomes

Description: Description in patients with Sars-CoV-2 infection the evolution of the symptoms (disturbances of smell and taste) understood as partial or total regression by 1-month and 3-month follow-up

Measure: Description of the disturbances of smell and taste

Time: Until patient discharge from the hospital (approximately four months)

Description: Define which factors (demographic and clinical) influence the improvement of the sense of smell and taste

Measure: Description of factors that influence smell and taste

Time: Until patient discharge from the hospital (approximately four months).


No related HPO nodes (Using clinical trials)